Outcomes after 20 years of experience in minimally invasive living-donor nephrectomy

TitleOutcomes after 20 years of experience in minimally invasive living-donor nephrectomy
Publication TypeJournal Article
Year of Publication2022
AuthorsMusquera M, Peri L, D'Anna M, Ajami T, Ribal MJ, Vilaseca A, Revuelta I, Álvarez-Vijande R, Palacios A, Diekmann F, Monsalve C, Tena B, Izquierdo L, Martos R, Paredes D, Beltran J, Oppenheimer F, Alcaraz A
Volume40
Issue3
Pagination07
Date PublishedMar
Abstract

Introduction: The transperitoneal laparoscopic approach is considered the gold standard technique for living kidney donation. Other accepted laparoscopic techniques include the retroperitoneal approach, natural orifice transluminal endoscopic surgery (NOTES)-assisted, laparo-endoscopic single-site surgery (LESS), with excellent results in the donor and graft. Many studies have compared these techniques with open ones. Our objective is to describe our experience and results in minimally invasive living-donor nephrectomies (MILDN): laparoscopic, NOTES-assisted, and LESS since their introduction in March 2002.
Materials and methods: We conducted a retrospective observational study of donors undergoing MILDN between March 2002 and March 2020.
Results: A total of 714 MILDNs were performed at our centre. All were completed, except for one, because of recipient death. The conventional laparoscopic approach was used in 541 cases (75.88%), NOTES in 116 (16.9%), LESS in 55 (7.7%), and one mini open (0.14%). Two-thirds of the donors were females (478 cases). The mean donor age was 52.87 years (SD 10.93). Six donors (0.8%) were diagnosed beforehand with a small renal mass, which was removed before transplantation in bench surgery. The right kidney was removed in 17.8% of cases. Warm ischaemia time was higher in the NOTES and LESS groups. We had eight conversions. The global intraoperative and postoperative complication rates were 6.8% and 4.9%, respectively. None of the donors developed renal disease during follow-up (mean 3.68 years). Five-year recipient and graft survival rates were 98.8% and 96.8%, respectively.
Conclusions: MILDN techniques are safe for donors and grafts, with low complication.

DOI10.1007/s00345-021-03912-1
Notify Library Reference ID4942